JP2013103903A5 - - Google Patents

Download PDF

Info

Publication number
JP2013103903A5
JP2013103903A5 JP2011248310A JP2011248310A JP2013103903A5 JP 2013103903 A5 JP2013103903 A5 JP 2013103903A5 JP 2011248310 A JP2011248310 A JP 2011248310A JP 2011248310 A JP2011248310 A JP 2011248310A JP 2013103903 A5 JP2013103903 A5 JP 2013103903A5
Authority
JP
Japan
Prior art keywords
group
external preparation
methyl
general formula
compound represented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011248310A
Other languages
English (en)
Japanese (ja)
Other versions
JP6246993B2 (ja
JP2013103903A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2011248310A priority Critical patent/JP6246993B2/ja
Priority claimed from JP2011248310A external-priority patent/JP6246993B2/ja
Publication of JP2013103903A publication Critical patent/JP2013103903A/ja
Publication of JP2013103903A5 publication Critical patent/JP2013103903A5/ja
Application granted granted Critical
Publication of JP6246993B2 publication Critical patent/JP6246993B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011248310A 2011-11-14 2011-11-14 皮膚外用剤 Active JP6246993B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2011248310A JP6246993B2 (ja) 2011-11-14 2011-11-14 皮膚外用剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2011248310A JP6246993B2 (ja) 2011-11-14 2011-11-14 皮膚外用剤

Publications (3)

Publication Number Publication Date
JP2013103903A JP2013103903A (ja) 2013-05-30
JP2013103903A5 true JP2013103903A5 (enExample) 2014-12-25
JP6246993B2 JP6246993B2 (ja) 2017-12-13

Family

ID=48623726

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011248310A Active JP6246993B2 (ja) 2011-11-14 2011-11-14 皮膚外用剤

Country Status (1)

Country Link
JP (1) JP6246993B2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX391864B (es) * 2014-04-03 2025-03-21 Pola Chem Ind Inc Inhibidor de melanogénesis que comprende alcohol d-pantotenílico, y cosmético de blanqueamiento de la piel que contiene el mismo inhibidor de melanogénesis.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002187816A (ja) * 2000-10-10 2002-07-05 Noevir Co Ltd 美白化粧料
JP2002179547A (ja) * 2000-12-08 2002-06-26 Isehan:Kk 美白化粧料
JP2005306831A (ja) * 2004-04-20 2005-11-04 Sakamoto Yakusoen:Kk 皮膚外用剤
JP2007161591A (ja) * 2005-12-09 2007-06-28 Naris Cosmetics Co Ltd メラニン産生阻害皮膚外用剤
EP2380567B1 (en) * 2008-12-22 2019-01-16 Pola Chemical Industries Inc. Melanin production inhibitor
JP2011068574A (ja) * 2009-09-24 2011-04-07 Pola Chemical Industries Inc 皮膚外用剤

Similar Documents

Publication Publication Date Title
JP2009143956A5 (enExample)
BR112013013950A2 (pt) antagonista de lpa1 policíclico e usos dos mesmos
NO20090328L (no) Nye forbindelser 385
WO2008100867A3 (en) Novel inhibitors hepatitis c virus replication
UA109421C2 (uk) Фармацевтична композиція, яка містить ліганди сигма-рецептора
TW200608972A (en) Aryl-pyridine derivatives
MX2010005824A (es) Derivados de aminotiazol.
JP2012502037A5 (enExample)
MX2009003939A (es) Derivados de imidazolona e imidazolidinona como inhibidores de la 11-beta-hidroxiesteroide deshidrogenasa de tipo 1 para diabetes.
JP2009102342A5 (enExample)
NZ590355A (en) Stat3 inhibitor containing quinolinecarboxamide derivative as active ingredient
JP2013518832A5 (enExample)
EA200901573A1 (ru) Гетероарилзамещенные тиазолы
NZ609874A (en) Crystalline naloxol-peg conjugate
MA34055B1 (fr) Chlorhydrate d'agomelatine hydrate et sa preparation
JP2016513108A5 (ja) 治療用化合物
MA29653B1 (fr) Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2011047055A8 (en) Novel mek inhibitors, useful in the treatment of diseases
JP2011046708A5 (enExample)
CN101031562A (zh) 咪唑-5-羧酸类衍生物、制备方法及其应用
JP2013103902A5 (enExample)
JP2013103903A5 (enExample)
WO2011102668A3 (ko) 콜키친 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조 방법 및 이를 포함하는 약학 조성물
MX2011011716A (es) Derivados de isoquinolina novedosos.
JP2011518843A5 (enExample)